Icosavax,
Biotechnology Research · 11 Employees
Email Address: info@icosavax.com
- Overview
- Employees
Access 40 Verified Employees Profiles for Icosavax,Unlock Free Contacts Now
About
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle. Icosavax is a member of the AstraZeneca Group.
Website
Year Founded
2018
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
1930 Boren Ave
Suite 1000
Seattle, Washington 98101, US
Keywords
Vaccine DevelopmentInfectious DiseaseVLPsRSVRespiratory syncytial virusVaccinesVaccine
Location
- 1930 Boren Ave Suite 1000 Seattle, Washington 98101, US
Email Formats
Sign up for free credits and discover verified email addresses of Icosavax,
FormatExamples
first + last
andywarhol@astrazeneca.com
first_initial + last
awarhol@astrazeneca.com
first + last_initial
andyw@astrazeneca.com
first
andy@astrazeneca.com
last
warhol@astrazeneca.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Icosavax, and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.